Stay updated on AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page.

Latest updates to the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page
- Check6 days agoChange DetectedRevision history adds v3.4.3 and removes v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed the lapse-in-government-funding notice and the Revision: v3.4.1.SummaryDifference0.9%

- Check41 days agoChange DetectedThe history shows a new site-wide notice about government funding and a new revision tag (v3.4.1) in place of the deleted v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check48 days agoChange DetectedAdditions introduce a glossary display and color-coded change indicators (green for additions, red for deletions) along with a new revision label (v3.4.0) on the Record History page. Deletions remove the old No FEAR Act data note and the v3.3.4 revision text; these are UI and versioning changes rather than core study content—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check84 days agoChange DetectedThe record history now shows Revision: v3.3.3; the items HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check106 days agoChange DetectedRevision history shows the addition of Revision: v3.3.2 and the removal of Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page.